2022
Current Progress in Vascular Engineering and Its Clinical Applications
Jouda H, Murillo L, Wang T. Current Progress in Vascular Engineering and Its Clinical Applications. Cells 2022, 11: 493. PMID: 35159302, PMCID: PMC8834640, DOI: 10.3390/cells11030493.Peer-Reviewed Original ResearchConceptsSmall diameter vascular conduitsAutologous vesselsVascular tissue engineeringHealthy autologous vesselsTensile strengthBiodegradable synthetic materialsTissue engineeringVascular engineeringTEVGsLarge-scale productionSynthetic materialsPromising solutionAdvanced technologiesVascular graftsEngineeringVascular scaffoldsGreat challengeVascular conduitsScaffoldsApplicationsMesenchyme stem cellsBiocompatibilityAdditional difficultiesKey factorsStrength
2018
Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds
Ali Z, Galougahi K, Shlofmitz R, Maehara A, Mintz G, Abizaid A, Chamié D, Hill J, Serruys P, Onuma Y, Stone G. Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds. Expert Review Of Cardiovascular Therapy 2018, 16: 431-440. PMID: 29732926, DOI: 10.1080/14779072.2018.1473034.Peer-Reviewed Original ResearchChapter 41 Stents and the Endothelium
Costa J, Chamie D, Sousa J, Abizaid A. Chapter 41 Stents and the Endothelium. 2018, 597-608. DOI: 10.1016/b978-0-12-812348-5.00041-6.Peer-Reviewed Original ResearchAcute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry.
Baumbach A, Zaman A, West NEJ, O'Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, de Belder A, Bouras G, Lansky A, Hill J, Mathur A, de Belder MA, Banning AP. Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry. EuroIntervention 2018, 13: 1554-1560. PMID: 29131802, DOI: 10.4244/eij-d-17-00886.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAcute Coronary SyndromeAdultClinical Decision-MakingCoronary Artery DiseaseCoronary ThrombosisFemaleHumansMaleMiddle AgedPatient SelectionPercutaneous Coronary InterventionPractice Patterns, Physicians'Product Surveillance, PostmarketingProspective StudiesProsthesis DesignRegistriesRisk FactorsTime FactorsTreatment OutcomeUnited KingdomConceptsBioresorbable vascular scaffoldDe novo coronary lesionsOne-year clinical outcomesIndependent clinical events committeeMajor adverse cardiac eventsAbsorb bioresorbable vascular scaffoldCareful implantation techniqueAdverse cardiac eventsNovo coronary lesionsTarget lesion failureAcute coronary syndromeClinical events committeeB2/CCareful patient selectionContemporary drug-eluting stentsDrug-eluting stentsVascular scaffoldsSmall vessel sizeDefinite STCoronary syndromeLesion failureCardiac eventsPatient ageReal-world practiceBVS implantation
2017
The Mirage microfiber sirolimus eluting coronary scaffold
Santoso T, Bang L, Costa R, Chamié D, Su S, Abizaid A, Onuma Y, Serruys P. The Mirage microfiber sirolimus eluting coronary scaffold. 2017, 316-318. DOI: 10.1201/9781315380629-36.Peer-Reviewed Original ResearchRandomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging
Tenekecioglu E, Serruys P, Onuma Y, Costa R, Chamié D, Sotomi Y, Yu T, Abizaid A, Liew H, Santoso T. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging. JACC Cardiovascular Interventions 2017, 10: 1115-1130. PMID: 28527768, DOI: 10.1016/j.jcin.2017.03.015.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary RestenosisCoronary StenosisCoronary VesselsFemaleHumansIndonesiaMalaysiaMaleMiddle AgedMultimodal ImagingPercutaneous Coronary InterventionPredictive Value of TestsProspective StudiesProsthesis DesignRisk FactorsSingle-Blind MethodSirolimusTime FactorsTomography, Optical CoherenceTreatment OutcomeConceptsAbsorbing devicesMicrofiber scaffoldsVascular scaffoldsGeneration of bioresorbable scaffoldsBioresorbable vascular scaffoldNovel mechanical propertiesSquare strutsAbsorb bioresorbable vascular scaffoldMechanical propertiesIn-deviceBioresorbable scaffoldsOptical coherence tomographyMinimal luminal diameterDiameter stenosisDevicesScaffoldsAbsorberCoherence tomographyFollow-upLate lossStudy groupDiameterLuminal diameterMedium-term safetyOptimal implant
2016
INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD
de Ribamar Costa J, Abizaid A, Chamie D, Lansky A, Kochman J, Koltowski L. INITIAL RESULTS OF THE FANTOM 1 TRIAL: A FIRST-IN-MAN EVALUATION OF A NOVEL, RADIOPAQUE SIROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD. Journal Of The American College Of Cardiology 2016, 67: 232. DOI: 10.1016/s0735-1097(16)30233-9.Peer-Reviewed Original Research
2013
Modificações na angulação coronária após implante de suporte vascular bioabsorvível e de stents de cromo-cobalto e aço inoxidável
Veloso e Silva M, Costa J, Abizaid A, Staico R, Taiguara D, Borghi T, Costa R, Chamié D, Sousa A, Sousa J. Modificações na angulação coronária após implante de suporte vascular bioabsorvível e de stents de cromo-cobalto e aço inoxidável. Journal Of Transcatheter Interventions 2013, 21: 332-337. DOI: 10.1590/s2179-83972013000400006.Peer-Reviewed Original ResearchMetal platformAngulation changesBioresorbable vascular scaffoldCobalt-chromiumStainless steelSecond-generation drug-eluting stentsStainless steel platformNative coronary arteriesSteel platformTreated with bioresorbable vascular scaffoldStent materialCobalt-chromium platformDrug-eluting stentsVascular scaffoldsClinical impactCoronary angulationRetrospective analysisDevice implantationStent implantationTreated segmentCoronary arteryVessel angulationAngulationStentComplex cohortComparação da retração aguda do stent entre o suporte vascular bioabsorvível eluidor de everolimus e dois diferentes stents metálicos farmacológicos
Borghi T, Costa J, Abizaid A, Chamié D, Veloso e Silva M, Taiguara D, Costa R, Staico R, Feres F, Chaves Á, Siqueira D, Sousa A, Sousa J. Comparação da retração aguda do stent entre o suporte vascular bioabsorvível eluidor de everolimus e dois diferentes stents metálicos farmacológicos. Journal Of Transcatheter Interventions 2013, 21: 326-331. DOI: 10.1590/s2179-83972013000400005.Peer-Reviewed Original ResearchMetallic drug-eluting stentsPercutaneous coronary interventionDrug-eluting stentsBioresorbable vascular scaffoldAcute recoilSecond-generation metallic drug-eluting stentsAcute luminal gainNon-complex lesionsAngiographic characteristicsNo significant differenceEverolimus-eluting stentPolymeric materialsMaximum inflation pressureCoronary interventionBalloon deflationStentCobalt-chromium everolimus-eluting stentPatientsSignificant differenceVascular scaffoldsBiolimus-eluting stentInflation pressureLuminal gainHealing processBalloonTCT-427 Comparison of Acute Stent Recoil Between the Everolimus-Eluting Bioresorbable Vascular Scaffold and Two different Drug-Eluting Metallic Stents
Campostrini T, Costa J, Abizaid A, Abizaid A, Chamié D, Staico R, Costa R, Veloso e Silva M, Siqueira D, Feres F, Silva D, Sousa A, Sousa J. TCT-427 Comparison of Acute Stent Recoil Between the Everolimus-Eluting Bioresorbable Vascular Scaffold and Two different Drug-Eluting Metallic Stents. Journal Of The American College Of Cardiology 2013, 62: b132. DOI: 10.1016/j.jacc.2013.08.1168.Peer-Reviewed Original ResearchSerial optical coherence tomography evaluation of the novel DESolve myolimus-eluting bioresorbable vascular scaffold for the treatment of de novo coronary artery lesions
Chamie D, Abizaid A, Costa J, Webster M, Stewart J, Costa R, Bhat V, Morrison L, Ormiston J, Verheye S. Serial optical coherence tomography evaluation of the novel DESolve myolimus-eluting bioresorbable vascular scaffold for the treatment of de novo coronary artery lesions. European Heart Journal 2013, 34: p3029. DOI: 10.1093/eurheartj/eht309.p3029.Peer-Reviewed Original ResearchBioresorbable scaffoldsOptical coherence tomographyDrug delivery capabilityScaffold dimensionsNeointimal hyperplasiaIsolation strutsStructural discontinuitiesReduce late stent thrombosisFollow-upPolymeric strutsAngular sectorStrut levelFirst-in-human evaluationOptical coherence tomography evaluationTreatment of de novo coronary artery lesionsStrutsPrevent vessel recoilDegree of neointimal hyperplasiaNeointimal hyperplasia thicknessIndependent core laboratoryThin layerVascular scaffoldsScaffold areaAnti-platelet therapyScaffold expansionProspective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints
Abizaid A, Schofer J, Meng M, Witzenbichler B, Bothelho R, Costa J, Chamie D, Medical I, Ormiston J, Verheye S. Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints. European Heart Journal 2013, 34: p5547. DOI: 10.1093/eurheartj/eht310.p5547.Peer-Reviewed Original ResearchMajor adverse cardiac eventsCoronary scaffoldsBioresorbable coronary scaffoldsCoronary artery lesionsPercutaneous coronary interventionProcedural successClinical endpointsPolylactide-based polymersVascular scaffoldsArtery lesionsBioresorbable vascular scaffoldComposite endpoint of cardiac deathAnnually to 5 yearsEndpoint of cardiac deathMultiple clinical endpointsDe novo coronary artery lesionsDrug-eluting bioresorbable vascular scaffoldsAdverse cardiac eventsLong-term scaffoldTarget lesion revascularizationNative coronary artery lesionsTarget vessel revascularizationMultiple imaging modalitiesTarget vessel MIOCT assessmentChanges in Coronary Angulation After Bioresorbable Vascular Scaffold and Cobalt-Chromium and Stainless Steel Stent Implantation
Veloso e Silva M, Costa J, Abizaid A, Staico R, Taiguara D, Borghi T, Costa R, Chamié D, Sousa A, Sousa J. Changes in Coronary Angulation After Bioresorbable Vascular Scaffold and Cobalt-Chromium and Stainless Steel Stent Implantation. Journal Of Transcatheter Interventions 2013, 21: 332-337. DOI: 10.1016/s2214-1235(15)30155-1.Peer-Reviewed Original ResearchMetal platformBioresorbable vascular scaffoldVascular scaffoldsCoronary angulationCobalt-chromiumAngulation changesStainless steelStainless steel platformSteel platformStent implantationStent materialCobalt-chromium platformSecond-generation drug-eluting stentsNative coronary arteriesGeometric changesTreated with bioresorbable vascular scaffoldDrug-eluting stentsClinical impactRetrospective analysisDevice implantationTreated segmentCoronary arteryScaffoldsAngulationSteelComparison of Acute Stent Recoil Between the Everolimus-Eluting Bioresorbable Vascular Scaffold and Two Different Drug-Eluting Metallic Stents
Borghi T, Costa J, Abizaid A, Chamié D, Veloso e Silva M, Taiguara D, Costa R, Staico R, Feres F, Chaves Á, Siqueira D, Sousa A, Sousa J. Comparison of Acute Stent Recoil Between the Everolimus-Eluting Bioresorbable Vascular Scaffold and Two Different Drug-Eluting Metallic Stents. Journal Of Transcatheter Interventions 2013, 21: 326-331. DOI: 10.1016/s2214-1235(15)30154-x.Peer-Reviewed Original ResearchMetallic drug-eluting stentsBackgroundBioresorbable vascular scaffoldsSecond-generation metallic drug-eluting stentsVascular scaffoldsDrug-eluting metal stentsAcute recoilPolymeric materialsBioresorbable vascular scaffoldPercutaneous coronary interventionInflation pressureStent recoilDrug-eluting stentsLuminal gainAcute stent recoilAcute luminal gainScaffoldsEverolimus-eluting bioresorbable vascular scaffoldDrug elutionMaximum inflation pressureNon-complex lesionsDiameterVessel wallMethodsFifty patientsAngiographic characteristicsEverolimus-eluting stent
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply